Along with a host of other reasons, I would imagine that the infatuation with Ponatinib earlier lines had some correlation with Denner's attempt to remove Berger.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.